Management of primary cutaneous lymphomas during the COVID-19 pandemic
- PMID: 33972055
- PMCID: PMC7794059
- DOI: 10.1016/j.clindermatol.2020.12.014
Management of primary cutaneous lymphomas during the COVID-19 pandemic
Abstract
Primary cutaneous lymphomas are defined as a heterogenic group of T- and B-cell non-Hodgkin lymphomas that present initially in the skin. Patients with primary cutaneous lymphomas are at a higher risk for developing complications in case of infection with the novel coronavirus severe acute respiratory syndrome coronavirus 2. The coronavirus disease 2019 (COVID-19) pandemic has affected the established diagnostic approach, staging, and therapeutic guidelines in patients with primary cutaneous lymphomas. In the light of the current global health crisis, management of primary cutaneous lymphomas needs to be adjusted. The key to achieving this is to balance the optimal control of the lymphoma, with a minimal increase of the personal risk for COVID-19 exposure and complications.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Figures
References
-
- Kempf W, Zimmermann AK, Mitteldorf C. Cutaneous lymphomas—an update 2019. Hematol Oncol. 2019;37(Suppl 1):43–47. - PubMed
-
- Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020;323:709–710. - PubMed
-
- WHO Coronavirus Disease (COVID-19) Dashboard 2020. Available at: https://covid19.who.int/. Accessed on 5 August 2020.
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
